These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 545349

  • 1. [On the polymorphism of barbiturates in powders and tablets - Part 3: The effect of the pressing power on the modification of barbital (author's transl)].
    Pintye-Hódi K, Hollenbach K.
    Pharmazie; 1979 Dec; 34(12):807-8. PubMed ID: 545349
    [Abstract] [Full Text] [Related]

  • 2. [On the Polymorphism of barbiturates in powders and tablets. Part 4: the dissolution of barbital B and barbital A (modifications I and III and their release from tablets (author's transl)].
    Hollenbach K, Pintye-Hódi K, Kedvessy G.
    Pharmazie; 1980 Jan; 35(1):32-5. PubMed ID: 7384174
    [Abstract] [Full Text] [Related]

  • 3. [On the polymorphism of barbiturates in powders and tablets. Part 1: Crystal optical studies on, and melting behaviour of barbital (author's transl)].
    Hollenbach K, Pintye-Hódi K, Kedvessy G.
    Pharmazie; 1979 Jan; 34(3):164-7. PubMed ID: 450956
    [Abstract] [Full Text] [Related]

  • 4. [On the polymorphism of barbiturates in powders and tablets. Part 2: On the infrared spectroscopy and the X-ray diffractometry of barbital (author's transl)].
    Hollenbach K, Mezösi J, Pintye-Hódi K, Kedvessy G.
    Pharmazie; 1979 Apr; 34(4):240-2. PubMed ID: 482331
    [Abstract] [Full Text] [Related]

  • 5. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K, Pintye-Hódi K, Kedvessy G.
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [Abstract] [Full Text] [Related]

  • 6. [On the polymorphism of barbiturates in powders and tablets. 6: Properties and behaviour of a spray-dried barbital preparation].
    Matzkó-Hollenbach K, Pintye-Hódi K, Kedvessy G.
    Pharmazie; 1982 Aug; 37(8):562-5. PubMed ID: 7146063
    [Abstract] [Full Text] [Related]

  • 7. Studies on the polymorphism of barbital.
    Grabowska I, Kaliszan R.
    Pol J Pharmacol Pharm; 1976 Aug; 28(5):529-36. PubMed ID: 1012979
    [Abstract] [Full Text] [Related]

  • 8. [The polymorphism of drugs in powders and tablets. 1. The preparation and characterization of polymorphic modifications of phenobarbital].
    Traue J, Kala H, Wenzel U, Wiegeleben A, Pintye-Hódi K, Szabó-Révész P, Miseta M, Selmeczi B, Kedvessy G.
    Pharmazie; 1987 Feb; 42(2):86-9. PubMed ID: 3602065
    [Abstract] [Full Text] [Related]

  • 9. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
    Javadzadeh Y, Mohammadi A, Khoei NS, Nokhodchi A.
    Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
    [Abstract] [Full Text] [Related]

  • 10. [Polymorphism of drugs in powders and tablets. 6. X-ray diffractometric studies of polymorphic modifications of tolbutamide].
    Traue J, Kala H, Köhler M, Wenzel U, Förster B, Pollandt P, Pintye-Hódi K, Szabó-Révész P, Selmeczi B.
    Pharmazie; 1987 Apr; 42(4):240-1. PubMed ID: 3615554
    [Abstract] [Full Text] [Related]

  • 11. [Deformation phenomena occurring during compression. I].
    Kovács B, Pintyéné Hódi K, Selmeczi B.
    Acta Pharm Hung; 1990 May; 60(2-3):49-55. PubMed ID: 2386072
    [Abstract] [Full Text] [Related]

  • 12. [Barbital buffer in tablets as a solvent for complement fixation test (CFT)].
    Królak M, Janicki S, Starostka K, Błaszczyk B.
    Pol Arch Weter; 1982 May; 23(2):111-22. PubMed ID: 7167394
    [Abstract] [Full Text] [Related]

  • 13. [Deformation phenomena occurring during compression. II].
    Pintyéné Hódi K, Kovács B, Selmeczi B.
    Acta Pharm Hung; 1990 May; 60(2-3):100-7. PubMed ID: 2386071
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern.
    Takehira R, Momose Y, Yamamura S.
    Int J Pharm; 2010 Oct 15; 398(1-2):33-8. PubMed ID: 20674727
    [Abstract] [Full Text] [Related]

  • 15. [Unexpected interactions of some psychotropic drugs with barbital and pentobarbital effects in mice (author's transl)].
    Simon P, Chermat R, Doaré L, Bourin M, Farinotti R.
    J Pharmacol; 1982 Oct 15; 13(2):241-52. PubMed ID: 7098486
    [Abstract] [Full Text] [Related]

  • 16. Effect of compression force on the crystal properties of erythromycin acistrate tablets.
    Riippi M, Tanninen V, Yliruusi J.
    Eur J Pharm Biopharm; 2000 Nov 15; 50(3):365-71. PubMed ID: 11072193
    [Abstract] [Full Text] [Related]

  • 17. Nano- and macro-geometrical structural change of caffeine and theophylline anhydrate tablets during hydration process by using X-ray computed tomography.
    Otsuka M, Ibe K, Tokudome Y, Ohshima H.
    Colloids Surf B Biointerfaces; 2009 Oct 15; 73(2):351-9. PubMed ID: 19559580
    [Abstract] [Full Text] [Related]

  • 18. The effect of crystal morphology and mill type on milling induced crystal disorder.
    Chikhalia V, Forbes RT, Storey RA, Ticehurst M.
    Eur J Pharm Sci; 2006 Jan 15; 27(1):19-26. PubMed ID: 16246535
    [Abstract] [Full Text] [Related]

  • 19. [The polymorphism of drugs in powders and tablets. 2. X-ray diffraction studies of polymorphic modifications of phenobarbital].
    Traue J, Kala H, Wenzel U, Förster B, Pintyehódi K, Szabó P, Miseta M, Selmeczi B, Kedvessy G.
    Pharmazie; 1986 Apr 15; 41(4):291-2. PubMed ID: 3725878
    [No Abstract] [Full Text] [Related]

  • 20. [On some parameters for the investigation and evaluation of the deformation behaviour of powder mixtures during tabletting (author's transl)].
    Dinev P, Welikowa E.
    Pharmazie; 1981 Apr 15; 36(1):37-40. PubMed ID: 7220584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.